Applied Genetic Technologies reported $126.97M in Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Alimera Sciences ALIM:US $ 62.1M 16.52M
Applied Genetic Technologies AGTC:US $ 126.97M 2.7M
Avrobio Inc AVRO:US $ 238.1M 7.82M
Biogen BIIB:US $ 24470.4M 615.7M
Bluebird Bio BLUE:US $ 1454.46M 182.82M
Celldex Therapeutics CLDX:US $ 204.55M 14.51M
Cti Biopharma CTIC:US $ 77.5M 34.71M
Gilead Sciences GILD:US $ 67984M 492M
Insmed INSM:US $ 1.23B 537.39M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
Life Technologies LIFE:US $ 49M 6.13M
Regeneron Pharmaceuticals REGN:US $ 21485.9M 3713.7M
Rigel Pharmaceuticals RIGL:US $ 201.6M 14.4M
Ultragenyx Pharmaceutical RARE:US $ 1512.44M 85.32M